chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nauseated; Extreme headache; fever; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Oct2022 at 14:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 47 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose: 01; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (Dose: 02; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (Dose: 03; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 18Oct2022 at 22:45, outcome "recovering", described as "Extreme headache"; CHILLS (non-serious) with onset 18Oct2022 at 22:45, outcome "recovering"; PYREXIA (non-serious) with onset 18Oct2022 at 22:45, outcome "recovering", described as "fever"; NAUSEA (non-serious) with onset 18Oct2022 at 22:45, outcome "recovering", described as "nauseated". Therapeutic measures were not taken as a result of nausea, headache, pyrexia, chills. Additional information: The patient did not receive any other vaccines within four weeks or any other medications in two weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 2-month-old male patient who experienced stopped breathing temporarily. The patient received a dose on an unspecified date. Within a couple of seconds after being administered the PREVNAR 13, the patient stopped breathing temporarily and then was fine after a unknown duration. No additional information was available at the time of this report.
guess what same thing happened to her mom, big bumps on her arm and her mother ended up having surgery to cut the lipoma out; guess what same thing happened to her mom, big bumps on her arm and her mother ended up having surgery to cut the lipoma out; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), dose unknown via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for immunisation. The patient's medical history and concomitant medications was not reported. The patient experienced guess what same thing happened to her mom, big bumps on her arm and her mother ended up having surgery to cut the lipoma out, Therapeutic measures were taken as a result of guess what same thing happened to her mom, big bumps on her arm and her mother ended up having surgery to cut the lipoma out. The outcome of the events was unknown  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Excruciating pain that radiates down left arm and makes arm completely numb. Patient went to local clinic the day after her shot and her doctor told her the shot was most likely gave too high on the arm, could possibly be SIRVA.
Information has been received from a pharmacist concerning a female patient who on unspecified dates was vaccinated intramuscularly with her "first two doses" of GARDASIL and developed "dry heaves" for several hours following each of the vaccinations. The patient recovered on an unknown date. The patient called the pharmacist. Additional information has been requested.
Patient did not feel well for 2 days after second shot; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Patient did not feel well for 2 days after second shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced MALAISE (Patient did not feel well for 2 days after second shot). On 10-Mar-2021, MALAISE (Patient did not feel well for 2 days after second shot) had resolved.            No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-380869 (Patient Link).
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Aug2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "sulfa allergy" (unspecified if ongoing), notes: Name of Drug as Reported: Sulfa, Reaction: Allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a licensed practical nurse concerning a 59 year old patient of an unknown gender. Medical history and concurrent conditions were not reported. On 21-OCT-2014 the patient was vaccinated with a dose of ZOSTAVAX (frequency reported as once) lot # K000996, expiration date 13-MAR-2014, 0.65 ml, subcutaneous. Co-suspect and concomitant therapies were not reported. The licensed practical nurse stated patient received ZOSTAVAX that was exposed to 1C for 31 hours (supported by stability data). No adverse effects reported.  This is (1) of two (2) reports from the same source. Additional information has been requested.
This spontaneous report was received from a healthcare worker concerning to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 12-MAY-2014, the patient was vaccinated with one dose of GARDASIL (dose, strength, lot number and expiration date were not reported) intramuscular route. The healthcare worker reports that an improperly stored GARDASIL was administered on 12-MAY-2014. The healthcare worker reports that the GARDASIL, was exposed to a temperature of 34F for 30 minutes on 05-MAY-2014. No adverse effect reported. Additional information has been requested. These case is one (1) of ten (10) reports from the same reporter. (MARRS 1405USA011237, 1405USA013601, 1405USA013602, 1405USA013603, 1405USA013604, 1405USA013605, 1405USA013606, 1405USA013607, 1405USA013608 and 1405USA013609).
Low grade fever, chills, body aches, headache, nausea, diziness/lightheaded. Felt like the full flu for 24 hours about 12 hours after recieving the vaccine.
In the past I had a bicep injury. They gave me stem cell treatment. Beyond the normal shoulder pain, I had pain in the specific area of the original injury much more than anywhere else
A nurse reported that a 3 year old male received an injection of Prevnar on 11/9/00 and within 2 to 3 hours, he developed an injection site reaction characterized by an area a "quarter in size" of redness, swelling and tenderness. He also had the chills. On 11/10/00, the child was not feeling well. Follow up information received 12/29/2000 indicated the patient recovered.
Patient came in for a COVID vaccine and upon completing his paper work the tech asked him which shot he was wanting and what dose it would be for him. He informed the tech that this was his FIRST dose and that he preferred Pfizer. The patient did not have his insurance card on him so we billed the shot according to the COVID. After receiving the shot, he received a copy of his insurance card electronically so we rebilled. They rejected stating this was a "different brand than his initial dose", meaning he had already had a dose. After looking into this, records show that he received J & J on 3/14/2021.
Information has been received from a physician concerning a 5 year old male who on an unspecified date was vaccinated with varicella virus vaccine live. On 12/24/03 the patient developed a fever. It was reported that from 12/25/03 through 12/30/03 the child developed a mild varicella like rash that consisted of roughly 30 lesions. From 12/31/03 through 1/1/04 the child seemed to be getting better. On 1/2/04 the child started to feel ill, described as lethargy and fever. On 1/03/04 the child was admitted to the hospital due to encephalitis. Both CSF and MRI were abnormal. The child was started on an unspecified antiviral therapy. On 1/8/04 the child was still in the hospital. Polymerase chain reaction was completed and negative for varicella, HSV, and enterovirus. On 1/14/04 it was reported that the child was still hospitalized and considered to be recovering. There was no product quality complaint involved. The reporter considered the patient's experience to be life threatening. Additional information has been requested.
This spontaneous report as received from a Community Nursing Service refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route not reported) lot # J003727, expiry date 07-NOV-2015. Additional information has been requested.
Delayed reaction to Moderna Covid-19 vaccine.  Rash itching, hot sensation on left arm where the 1st dose was administered.  This started happening 1 week after the injection.
She received her shot on 5/14/12 one week later she noticed inflammation at her administration site and two weeks later she was treated for inflammation by MD. A week after she was referred to orthopedic and per MD the shot was given her rotator cuff. She is being treated with cortisone shot. She is feeling lot better after cortisone shot.
Shingles; Blisters; Pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), administration date 02Apr2021 (Batch/Lot number: unknown) at the age of 74 years as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Shingle vaccine (In 2019 she had shingle vaccine), administration date: 2019, for Immunization. The following information was reported: HERPES ZOSTER (non-serious) with onset 2021, outcome "unknown", described as "Shingles"; BLISTER (non-serious) with onset 2021, outcome "recovered" (2021), described as "Blisters"; PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Pain".  Additional Information: 5 to 6 weeks ago patient developed shingles. She was able to get the two doses of the covid vaccine. Patient was planning to get the covid booster dose. She wanted to know the timing on when she could have the booster shot. Agent referred her to her hcp. Stated she can be followed up with and she was waiting for a call.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient presented to emergency department on 8/19/2021 with shortness of breath. He was found to be COVID-19 positive and admitted for further management. He was transferred to the ICU on 8/23/2021 due to worsening hypoxia. He was intubated on 8/28/2021. Patient's condition further deteriorated into multisystem organ failure. He was placed on comfort measures on and expired on 9/8/2021.
I had a persistent cough that would not go away, I could not sleep for a couple of nights, it was causing me chest pains from causing so much. I had body aches. I had a telehealth appointment, I was prescribed azithromycin, the symptoms went away for a while but did come back, I made an appointment with my doctor. Upon examination my NP-C said I was suffering from seasonal allergies. She suggested I try using Allergy. I have tried it and so far, my symptoms have gone and no more coughing.
One hour after receiving the MMR, Varicella and Hep A Vaccines the patient experienced a high fever (102-103) and a asthma attack. At this time the foster mother administered albuterol and called the primary MD. No additional interventions were recommended at this point and the patients symptoms resolved. 5 days later however, the patient spiked another fever (104 and was brought into the doctor. The MD was unable to determine whether or not the fever was caused by the vaccine. It was recommended that the patient receive his nebs before vaccine administration in the future. This event was the second time the patient experienced a high fever and asthma attack from shots. The first event happend at his primary care clinic.
No additional AE reported; an expired dose of ROTATEQ was administered to a patient.; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concomitant therapies and concurrent conditions were not provided.  On 07-JUL-2022, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 ml, lot # T030490, expiration date 21-APR-2022, administered orally (strength and dose number were not provided) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event).
He is a health care worker.  He presented without his CDC card.  He filled out the paperwork for consent.  He did not remember exact date he received his last Covid injection but it had been more than 2 months. At time of injection prior to injection he was asked if he had received a Bivalent he stated no.  When charting this information into patients Chart there was no indication he had received a Bivalent booster.  However in immunization system, immunization system stated he received the Mod bivalent 10/29/2022 by pharmacy.  He was still waiting his 15 minutes and was informed he had in fact received the bivalent vaccine in OCT and did not required this injection he received today. NO adverse reaction-no symptoms, no signs , no treatment, no reaction
No adverse event; Medical assitant reports the administration of improperly stored VAQTA; This spontaneous report has been received from a medical assistant, concerning a patient of unknown gender and age.   The patient's concurrent conditions, medical history and concomitant medication were not reported.  On 23-DEC-2021, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated(VAQTA) (lot # T031202  has been verified to be valid, expiration date 14-JUN-2022) (anatomical location not provided) for prophylaxis. Temperature was 50.5 farenheit (F), time frame 57 minutes with no previous excursion. No additional adverse events reported.
Day 1- 2 days after shot-violently sick, abdomen pain, heat in area, vomiting, felt like passing out,  bloating more than normal.  sick over time period of 5 hours.    Day 2- rest and next day very tired and stomach did not feel normal.  ate light that day and rested more than normal.   Day 3- back to normal feelings and eating.
pt recvd vax on 18JUN92; 19JUN92 approx 16 hrs following vax pt devel a mild rash on arms; skin felt crawley; devel nausea & pruritus;
1. Double vision. Saw opthalmologist. Diagnosed as Left 6th Nerve Palsy as a result of the vaccine. Started using eye patch. Condition unchanged. 2. Weakness in legs, difficulty controlling movement which started 48 hours after vaccination. Saw neurologist. Diagnosed as Ataxia. Conditioned worsened daily to a point. Presently neither improving nor worsening.  Currently conditions have reached a plateau, neither improving nor worsening.
Tired after the 2nd dose; Started feeling flu like; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Started feeling flu like) and FATIGUE (Tired after the 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Started feeling flu like). On an unknown date, the patient experienced FATIGUE (Tired after the 2nd dose). At the time of the report, INFLUENZA LIKE ILLNESS (Started feeling flu like) and FATIGUE (Tired after the 2nd dose) outcome was unknown.            No concomitant medication was reported.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events were not applicable.   Reporter did not allow further contact
On both shots I have a taste of metallic in my mouth. It was like this bizarre metallic taste as soon as I was injected with the vaccine the second one was more prominent and lasted a little longer. I felt nauseous when I got home
Severe fevers, chills, constant diarrhea, nursing constantly for 2.5 days, no sleep in 2.5 days, confusion (not recognizing parents), aches and pains, possible loss of sight (no reaction to light changes, movement, etc.), inconsolable crying, needing to be held non-stop, serious sweating and dehydration, slight writhing of limbs.
This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with improperly stored doses of doses of GARDASIL 9 lot number N004799 and expiration date of 15-NOV-2019 for prophylaxis (dose and route of administration were not reported) and M-M-R II rHA lot number L040960 with an expiration date of 16-OCT-2017 and lot number M045402 with an expiration date of 14-NOV-2018 for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature excursion of 47.1°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. No adverse effects were reported. This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1710USA006358: US-009507513-1710USA006359: US-009507513-1710USA006360: US-009507513-1710USA006361: US-009507513-1710USA006362: US-009507513-1710USA006363: US-009507513-1710USA006364: US-009507513-1710USA006365: US-009507513-1710USA006366: US-009507513-1710USA006367: US-009507513-1710USA006368: US-009507513-1710USA006369: US-009507513-1710USA006370: US-009507513-1710USA006371: US-009507513-1710USA006372: US-009507513-1710USA006373: US-009507513-1710USA006357: US-009507513-1710USA006355: US-009507513-1710USA006356:
On 10/30/23 client stated that his left upper arm was sore following an injection. Nursing assessed the area and noted that. 70cm x 110 cm bright pink area noted on Left deltoid. Warm to touch. Client stated it is slightly painful to the touch.
Patient developed hive like rash on extremites and puffiness/redness of face 27 minutes after injection.
This case was reported by a consumer and described the occurrence of shortness of breath in a male subject aged between 30 and 39 years old who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included dust mites allergy, gluten intolerance, lactose intolerance, latex allergy, migraine, penicillin allergy, seasonal allergy and soy intolerance. In 2007 the subject received unspecified dose of Hepatitis B vaccine (unknown). I 2007, at an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced shortness of breath and panic attack. Details regarding the vaccination or events were not provided. At the time of reporting the outcome of the events were unspecified. The subject experienced adverse event with BOOSTRIX vaccine, for that case please see A1062563A. Follow-up information was received on 04 March 2014 via consumer. Additional concurrent medical conditions included allergy to pet dander, grass allergy, pollen allergy and tree allergy. Historic vaccination included tetanus vaccine (non-gsk); non=GSK manufacturer;unknown; unknown given in 2008. The subject reported the shortness of breath from the Hepatitis B vaccine and lasted a couple of seconds. No other information was provided. The subject experienced adverse events with BOOSTRIX vaccine, for that case please see A1062563A and with previous flu vaccine, please see case A1062563C.
pt states pt recv flu shot on rt arm & pneumococcal in lt arm;lt arm became swollen, red & painful from the elbow to the shoulder & could not move it w/o pain on Thursday 5DEC96;went to ER;MD stated was infect from the inj;
On 11/10/09 Pt was brought by dad to doctors office because red "bumps" noted 1 1/2 days prior to the visit. It was pruritic somewhat but it did not seem to bother her. She had no fever nor any other s/s. On examination, she had scattered lesions of different types on her body: some raised papules; papulo-vesicular and some crusted especially on the nape of her neck.
Patient had extreme nausea and diarrhea the first day after injection, we are reporting though a large red rash on right deltoid that started after the injection on the 20th that patient sought treatment for on 01/27/21
16 year old received Infanrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-year-old male patient who received DTPa (Infanrix) (batch number 7KM94, expiry date 10th June 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 29th April 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 29th April 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 29-Apr-2022 Reporter's comment: Medical assistant reported that on the day of reporting 16 years old patient received Infanrix instead of Boostrix. Consented to follow-up. Additional Supportive Information: The patient received Infanrix instead of Boostrix, which led to inappropriate age at vaccine administration. This case is linked with case US2022071957 reported by same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2022071957:Same reporter
On the evening of getting the shot, began to feel chilled. Over the next few days included body aches, loss of appetite, sore throat. On morning of 10/19 had to clean up a water spill. Afterward had chest pains - 911 was called - V-fib - flatline & resuscitation on route.